CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $570,000 | -54.8% | 145,108 | +71.1% | 0.01% | -50.0% |
Q2 2019 | $1,261,000 | -27.7% | 84,830 | +20.7% | 0.01% | -28.6% |
Q1 2019 | $1,745,000 | +22.0% | 70,297 | -11.7% | 0.01% | +16.7% |
Q4 2018 | $1,430,000 | -36.1% | 79,620 | +4.4% | 0.01% | -20.0% |
Q3 2018 | $2,239,000 | -23.9% | 76,231 | +17.9% | 0.02% | -25.0% |
Q2 2018 | $2,941,000 | +1.5% | 64,635 | +17.8% | 0.02% | +185.7% |
Q1 2018 | $2,897,000 | -19.0% | 54,855 | +4.3% | 0.01% | -12.5% |
Q4 2017 | $3,575,000 | -36.0% | 52,593 | -22.5% | 0.01% | -38.5% |
Q3 2017 | $5,589,000 | +8.5% | 67,842 | +23.3% | 0.01% | -7.1% |
Q2 2017 | $5,149,000 | +58.6% | 55,002 | +7.8% | 0.01% | +55.6% |
Q1 2017 | $3,247,000 | +15.0% | 50,999 | -19.8% | 0.01% | +12.5% |
Q4 2016 | $2,824,000 | +41.3% | 63,568 | -38.9% | 0.01% | +33.3% |
Q1 2016 | $1,999,000 | -51.2% | 104,121 | -11.1% | 0.01% | -50.0% |
Q4 2015 | $4,099,000 | -51.5% | 117,108 | +27.5% | 0.01% | -53.8% |
Q3 2015 | $8,448,000 | -8.0% | 91,867 | -12.1% | 0.03% | +13.0% |
Q2 2015 | $9,181,000 | +26.4% | 104,476 | +6.7% | 0.02% | +35.3% |
Q1 2015 | $7,266,000 | +36.6% | 97,891 | +3.0% | 0.02% | +30.8% |
Q4 2014 | $5,320,000 | +37.7% | 95,001 | +11.5% | 0.01% | +44.4% |
Q3 2014 | $3,864,000 | +13.1% | 85,187 | +3.3% | 0.01% | 0.0% |
Q2 2014 | $3,416,000 | -33.3% | 82,501 | +11.6% | 0.01% | -40.0% |
Q1 2014 | $5,121,000 | +19.6% | 73,932 | +4.1% | 0.02% | +15.4% |
Q4 2013 | $4,280,000 | +15.4% | 71,022 | +16.4% | 0.01% | 0.0% |
Q3 2013 | $3,710,000 | – | 61,040 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |